Novo Nordisk A/S(NYSE : NVO)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||-0.46%||168.10||0.7%||$1318.70m|
|MRK||Merck & Co., Inc.||0.65%||77.96||0.7%||$905.52m|
|BMY||Bristol-Myers Squibb Co.||0.33%||64.47||1.0%||$717.41m|
|LLY||Eli Lilly & Co.||-0.92%||192.96||1.1%||$575.86m|
|BTX||Brooklyn ImmunoTherapeutics, Inc.||-8.33%||28.05||12.8%||$320.94m|
|NVO||Novo Nordisk A/S||1.66%||77.90||0.1%||$65.72m|
|MNMD||Mind Medicine (MindMed), Inc.||-4.87%||2.93||0.0%||$60.73m|
Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in BagsvÃ¦rd, Denmark.